Company profile ACRX

Acelrx Pharmaceuticals Inc

acelrx pharmaceuticals inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain. the company’s product candidates, dsuvia™ (known as arx-04 outside of the united states) and zalviso®, are designed to deliver sufentanil, a strong opioid analgesic, via a non-invasive..., sublingual formulation in medical supervised settings. dsuvia is designed to deliver sublingual tablets containing 30 mcg sufentanil via a disposable, pre-filled, single-dose applicator. the phase 3 clinical program has completed and assessed the investigational product in the treatment of moderate-to-severe acute pain in patients who had undergone surgery or who presented to an emergency room with trauma or injury. in clinical studies, dsuvia demonstrated reductions in pain intensity as early as 15-to-30 minutes after the start of dosing and the most common adverse events included nausea, headache, dizziness, and v Show More

Google Trends for acelrx pharmaceuticals -stock
Q4 -54.3% YoY, -90.0% QoQ | Q1 -100.0% YoY, -100.0% QoQ | Correlation: 0.05

Quarter analysis & expected interestLast update: February 08 2024 12:54:19.

After 39 days of this quarter the interest is at 16.0. Based on that we can calculate that during remaining 52 days it will total up to 37.0.
acelrx pharmaceuticals -stock expected interest is significantly lower compared to same quarter last year (-50.0%) but similar to previous quarter.

Year	Q1	Q2	Q3	Q4
2019	51	101 98.0% QoQ	48 -52.5% QoQ	62 29.2% QoQ
2020	64 25.5% YoY 3.2% QoQ	287 184.2% YoY 348.4% QoQ	110 129.2% YoY -61.7% QoQ	150 141.9% YoY 36.4% QoQ
2021	252 293.8% YoY 68.0% QoQ	32 -88.9% YoY -87.3% QoQ	55 -50.0% YoY 71.9% QoQ	26 -82.7% YoY -52.7% QoQ
2022	118 -53.2% YoY 353.8% QoQ	83 159.4% YoY -29.7% QoQ	105 90.9% YoY 26.5% QoQ	33 26.9% YoY -68.6% QoQ
2023	74 -37.3% YoY 124.2% QoQ	24 -71.1% YoY -67.6% QoQ	0 -100.0% YoY -100.0% QoQ	55 66.7% YoY inf% QoQ
2024	16 -78.4% YoY -70.9% QoQ	-	-	-

this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.

Correlation between past revenue and acelrx pharmaceuticals -stock search interestLast update: February 08 2024 12:54:19.

Correlation coefficient between keyword and revenue is 0.61

Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.

Analysis of YoY 5Y Google Trends Last update: February 08 2024 12:54:23.

The average 5 years interest of acelrx pharmaceuticals -stock was 6.69 per week.
The last year interest of acelrx pharmaceuticals -stock compared to the last 5 years has changed by -58.89%.
This is something to be checked.
The last year interest is quite lower compared to 5 years ago. It has decreased by -49.63%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome

Google Trends for acelrx pharmaceuticals news
Q4 -70.8% YoY, -75.0% QoQ | Q1 -100.0% YoY, -100.0% QoQ | Correlation: 0.24

Quarter analysis & expected interestLast update: February 08 2024 12:54:29.

After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0.
acelrx pharmaceuticals news expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).

Year	Q1	Q2	Q3	Q4
2019	57	175 207.0% QoQ	169 -3.4% QoQ	44 -74.0% QoQ
2020	24 -57.9% YoY -45.5% QoQ	85 -51.4% YoY 254.2% QoQ	32 -81.1% YoY -62.4% QoQ	45 2.3% YoY 40.6% QoQ
2021	234 875.0% YoY 420.0% QoQ	198 132.9% YoY -15.4% QoQ	30 -6.2% YoY -84.8% QoQ	170 277.8% YoY 466.7% QoQ
2022	21 -91.0% YoY -87.6% QoQ	73 -63.1% YoY 247.6% QoQ	77 156.7% YoY 5.5% QoQ	49 -71.2% YoY -36.4% QoQ
2023	73 247.6% YoY 49.0% QoQ	22 -69.9% YoY -69.9% QoQ	31 -59.7% YoY 40.9% QoQ	45 -8.2% YoY 45.2% QoQ
2024	0 -100.0% YoY -100.0% QoQ	-	-	-

this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.

Correlation between past revenue and acelrx pharmaceuticals news search interestLast update: February 08 2024 12:54:29.

Correlation coefficient between keyword and revenue is -0.13

Analysis of YoY 5Y Google Trends Last update: February 08 2024 12:54:31.

The average 5 years interest of acelrx pharmaceuticals news was 6.34 per week.
The last year interest of acelrx pharmaceuticals news compared to the last 5 years has changed by -59.31%.
This is something to be checked.
The last year interest is quite lower compared to 5 years ago. It has decreased by -69.86%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome